Inhibitory activity and mechanism of silver nanoparticles against herpes simplex virus type 1

[1]  Dinesh Kumar,et al.  Green synthesis of silver nanoparticles using Indian Belladonna extract and their potential antioxidant, anti-inflammatory, anticancer and larvicidal activities , 2020, Plant Cell Reports.

[2]  V. Agrawal,et al.  Green synthesis of silver nanoparticles using Indian Belladonna extract and their potential antioxidant, anti-inflammatory, anticancer and larvicidal activities , 2020, Plant Cell Reports.

[3]  F. Duman,et al.  Biosynthesis of silver nanoparticles using leaf extract of Aesculus hippocastanum (horse chestnut): Evaluation of their antibacterial, antioxidant and drug release system activities. , 2020, Materials science & engineering. C, Materials for biological applications.

[4]  Yanli Wang,et al.  Green-Synthesization of Silver Nanoparticles Using Endophytic Bacteria Isolated from Garlic and Its Antifungal Activity against Wheat Fusarium Head Blight Pathogen Fusarium graminearum , 2020, Nanomaterials.

[5]  T. Vinković,et al.  Antifungal activities of silver and selenium nanoparticles stabilized with different surface coating agents. , 2020, Pest management science.

[6]  A. Tavakoli,et al.  Inhibition of Herpes Simplex Virus Type 1 by Copper Oxide Nanoparticles. , 2020, Journal of virological methods.

[7]  E. Cheuret,et al.  Neonatal Herpes Simplex Virus-1 Recurrence with Central Nervous System Disease in Twins after Completion of a Six-Month Course of Suppressive Therapy: Case Report , 2019, Neuropediatrics.

[8]  Ravikumar Vilwanathan,et al.  Annona muricata assisted biogenic synthesis of silver nanoparticles regulates cell cycle arrest in NSCLC cell lines. , 2019, Bioorganic chemistry.

[9]  Mohamed Farghali,et al.  Antiprotozoal activity of silver nanoparticles against Cryptosporidium parvum oocysts: New insights on their feasibility as a water disinfectant. , 2019, Journal of microbiological methods.

[10]  R. Handy,et al.  Antibacterial properties of silver nanoparticles grown in situ and anchored to titanium dioxide nanotubes on titanium implant against Staphylococcus aureus , 2019, Nanotoxicology.

[11]  T. Ivanciuc,et al.  Antiviral and Immunomodulatory Activity of Silver Nanoparticles in Experimental RSV Infection , 2019, Viruses.

[12]  A. Alsayari,et al.  Antiviral potential of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea , 2019, International journal of nanomedicine.

[13]  R. Ochoa,et al.  Anti-Herpetic, Anti-Dengue and Antineoplastic Activities of Simple and Heterocycle-Fused Derivatives of Terpenyl-1,4-Naphthoquinone and 1,4-Anthraquinone , 2019, Molecules.

[14]  Xiaozhen Liang,et al.  Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol , 2019, Virologica Sinica.

[15]  C. Fraefel,et al.  The Cyclin-Dependent Kinase 5 Inhibitor Peptide Inhibits Herpes Simplex Virus Type 1 Replication , 2019, Scientific Reports.

[16]  Guojun Wu,et al.  Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa , 2019, International journal of nanomedicine.

[17]  F. Baderca,et al.  Betulin silver nanoparticles qualify as efficient antimelanoma agents in in vitro and in vivo studies , 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  Subhadip Banerjee,et al.  Boswellia serrata oleo-gum-resin and β-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-кB and p38 MAP kinase signaling. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[19]  E. Mocarski,et al.  Herpes simplex virus 1 ICP6 impedes TNF receptor 1–induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles , 2018, The Journal of Biological Chemistry.

[20]  J. Yadav,et al.  Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus , 2018, Applied Microbiology and Biotechnology.

[21]  J. Yadav,et al.  Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus , 2018, Applied Microbiology and Biotechnology.

[22]  M. Sanaei,et al.  Medical and dental applications of nanomedicines , 2018, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[23]  Lin Chen,et al.  Species-Specific Deamidation of cGAS by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication. , 2018, Cell host & microbe.

[24]  A. Wald,et al.  Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals , 2018, The Journal of infectious diseases.

[25]  C. Nakamura,et al.  Parthenolide Influences Herpes simplex virus 1 Replication in vitro , 2018, Intervirology.

[26]  A. Baiker,et al.  β-Carboline derivatives as novel antivirals for herpes simplex virus. , 2018, International journal of antimicrobial agents.

[27]  Yu Xia,et al.  Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways , 2018, International journal of nanomedicine.

[28]  S. Tjong,et al.  Scalable Fabrication of High-Performance Transparent Conductors Using Graphene Oxide-Stabilized Single-Walled Carbon Nanotube Inks , 2018, Nanomaterials.

[29]  F. Gao,et al.  Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo , 2018, Viruses.

[30]  T. Ichinohe,et al.  Herpes Simplex Virus 1 VP22 Inhibits AIM2-Dependent Inflammasome Activation to Enable Efficient Viral Replication. , 2018, Cell host & microbe.

[31]  S. Fahad,et al.  Nanosilver: new ageless and versatile biomedical therapeutic scaffold , 2018, International journal of nanomedicine.

[32]  A. Rabinstein.  Herpes Virus Encephalitis in Adults: Current Knowledge and Old Myths. , 2017, Neurologic clinics.

[33]  Rakesh K. Sharma,et al.  Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic , 2017, Immunological investigations.

[34]  G. Benelli,et al.  Single-step biological fabrication of colloidal silver nanoparticles using Hugonia mystax: larvicidal potential against Zika virus, dengue, and malaria vector mosquitoes , 2017, Artificial cells, nanomedicine, and biotechnology.

[35]  Adriana Vulcu,et al.  In vitro and in vivo anti-inflammatory properties of green synthesized silver nanoparticles using Viburnum opulus L. fruits extract. , 2017, Materials science & engineering. C, Materials for biological applications.

[36]  S. Gurunathan,et al.  Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment , 2017, International journal of nanomedicine.

[37]  C. Patra,et al.  Biologically synthesized metal nanoparticles: recent advancement and future perspectives in cancer theranostics , 2017, Future science OA.

[38]  R. Longnecker,et al.  Structure-Based Mutations in the Herpes Simplex Virus 1 Glycoprotein B Ectodomain Arm Impart a Slow-Entry Phenotype , 2017, mBio.

[39]  K. Govindaraju,et al.  Microscopy based studies on the interaction of bio-based silver nanoparticles with Bombyx mori Nuclear Polyhedrosis virus. , 2017, Journal of virological methods.

[40]  Choon-Nam Ong,et al.  Biomedical Applications of Nanomaterials as Therapeutics. , 2017, Current medicinal chemistry.

[41]  C. Zheng,et al.  Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo , 2017, BMC Infectious Diseases.

[42]  A. Pichette,et al.  Chemical composition and anti-herpes simplex virus type 1 (HSV-1) activity of extracts from Cornus canadensis , 2017, BMC Complementary and Alternative Medicine.

[43]  K. O'Brien,et al.  Antiviral agents for infectious mononucleosis (glandular fever). , 2016, The Cochrane database of systematic reviews.

[44]  Jae U. Jung,et al.  CD95 Signaling Inhibits B Cell Receptor-Mediated Gammaherpesvirus Replication in Apoptosis-Resistant B Lymphoma Cells , 2016, Journal of Virology.

[45]  S. Gurunathan,et al.  Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy , 2016, International journal of nanomedicine.

[46]  B. Borrego,et al.  Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[47]  K. Gokulan,et al.  Dose and Size-Dependent Antiviral Effects of Silver Nanoparticles on Feline Calicivirus, a Human Norovirus Surrogate. , 2016, Foodborne pathogens and disease.

[48]  C. Huang,et al.  Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. , 2016, Nanoscale.

[49]  S. Weller,et al.  ICP8 Filament Formation Is Essential for Replication Compartment Formation during Herpes Simplex Virus Infection , 2015, Journal of Virology.

[50]  P. Mehrbod,et al.  In Vitro Antiviral Effect of "Nanosilver" on Influenza Virus , 2015 .

[51]  R. Hafidh,et al.  Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus −1: an in vitro study on virally infected Vero and MRC-5 cell lines , 2015, BMC Complementary and Alternative Medicine.

[52]  Zhe-Sheng Chen,et al.  Silver nanoparticles: synthesis, properties, and therapeutic applications. , 2015, Drug discovery today.

[53]  Chun-Nan Lee,et al.  Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection , 2015, PloS one.

[54]  M. Reka,et al.  Antibacterial and cytotoxic effect of biologically synthesized silver nanoparticles using aqueous root extract of Erythrina indica lam. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[55]  M. Umadevi,et al.  Antibacterial and catalytic activities of green synthesized silver nanoparticles. , 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[56]  M. Kukhanova,et al.  Human herpes simplex virus: Life cycle and development of inhibitors , 2014, Biochemistry (Moscow).

[57]  M. Crisan,et al.  Green synthesis, characterization and anti-inflammatory activity of silver nanoparticles using European black elderberry fruits extract. , 2014, Colloids and surfaces. B, Biointerfaces.

[58]  Shalini Sharma,et al.  Silver nanoparticles impair Peste des petits ruminants virus replication. , 2014, Virus research.

[59]  Ahmed Hamroush,et al.  Herpes Simplex epithelial keratitis associated with daily disposable contact lens wear. , 2014, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[60]  M. El-Naggar,et al.  Antimicrobial wound dressing and anti-inflammatory efficacy of silver nanoparticles. , 2014, International journal of biological macromolecules.

[61]  P. van Damme,et al.  Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial. , 2013, Vaccine.

[62]  Cong-long Zheng,et al.  Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro. , 2013, Journal of virological methods.

[63]  F. Benninger,et al.  Update on Herpes Virus Infections of the Nervous System , 2013, Current Neurology and Neuroscience Reports.

[64]  Linda J. Scarazzini,et al.  Central nervous system herpes simplex and varicella zoster virus infections in natalizumab-treated patients. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  Mark Hopkins,et al.  Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient. , 2013, The Journal of infectious diseases.

[66]  S. Jennings,et al.  Immunological control of herpes simplex virus infections , 2013, Journal of NeuroVirology.

[67]  H. Field,et al.  Recent developments in anti-herpesvirus drugs. , 2013, British medical bulletin.

[68]  S. Weller,et al.  Herpes simplex viruses: mechanisms of DNA replication. , 2012, Cold Spring Harbor perspectives in biology.

[69]  G. Opdenakker,et al.  In Vitro-Selected Drug-Resistant Varicella-Zoster Virus Mutants in the Thymidine Kinase and DNA Polymerase Genes Yield Novel Phenotype-Genotype Associations and Highlight Differences between Antiherpesvirus Drugs , 2011, Journal of Virology.

[70]  Stefania Galdiero,et al.  Silver Nanoparticles as Potential Antiviral Agents , 2011, Molecules.

[71]  P. Praus,et al.  Antibacterial and antifungal activities of silver, copper and zinc montmorillonites , 2011 .

[72]  Songqin Liu,et al.  Gold nanoparticle-based signal amplification for biosensing. , 2011, Analytical biochemistry.

[73]  H. H. Lara,et al.  Silver nanoparticles are broad-spectrum bactericidal and virucidal compounds , 2011, Journal of nanobiotechnology.

[74]  James M. Hill,et al.  Lytic HSV-1 infection induces the multifunctional transcription factor Early Growth Response-1 (EGR-1) in rabbit corneal cells , 2011, Virology Journal.

[75]  S. Habtemariam,et al.  In vitro anti HSV‐1 and HSV‐2 activity of Tanacetum vulgare extracts and isolated compounds: An approach to their mechanisms of action , 2010, Phytotherapy research : PTR.

[76]  G. Boivin,et al.  Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management , 2010, Antimicrobial Agents and Chemotherapy.

[77]  R. Eisenberg,et al.  Cascade of Events Governing Cell-Cell Fusion Induced by Herpes Simplex Virus Glycoproteins gD, gH/gL, and gB , 2010, Journal of Virology.

[78]  A. Schrand,et al.  Interaction of silver nanoparticles with Tacaribe virus , 2010, Journal of nanobiotechnology.

[79]  R. Sarid,et al.  Inhibition of HSV-1 attachment, entry, and cell-to-cell spread by functionalized multivalent gold nanoparticles. , 2010, Small.

[80]  E. Kern,et al.  Virucidal activity of polysaccharide extracts from four algal species against herpes simplex virus. , 2009, Antiviral research.

[81]  P. Tam,et al.  Further Evidence of the Anti‐inflammatory Effects of Silver Nanoparticles , 2009, ChemMedChem.

[82]  M. Hande,et al.  Cytotoxicity and genotoxicity of silver nanoparticles in human cells. , 2009, ACS nano.

[83]  Hui Li,et al.  HSV-2 induces TLRs and NF-kappaB-dependent cytokines in cervical epithelial cells. , 2009, Biochemical and biophysical research communications.

[84]  H. Hsieh,et al.  Anti-HSV activity of digitoxin and its possible mechanisms. , 2008, Antiviral research.

[85]  Saber M Hussain,et al.  A Preliminary Assessment of Silver Nanoparticle Inhibition of Monkeypox Virus Plaque Formation , 2008, Nanoscale Research Letters.

[86]  J. Luk,et al.  Silver Nanoparticles Inhibit Hepatitis B virus Replication , 2008, Antiviral therapy.

[87]  N. DeLuca,et al.  Binding of ICP4, TATA-Binding Protein, and RNA Polymerase II to Herpes Simplex Virus Type 1 Immediate-Early, Early, and Late Promoters in Virus-Infected Cells , 2007, Journal of Virology.

[88]  X. Nie,et al.  Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes. , 2006, Antiviral research.

[89]  S. Paludan,et al.  Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3. , 2006, The Journal of general virology.

[90]  Andrew J Davison,et al.  Topics in herpesvirus genomics and evolution. , 2006, Virus research.

[91]  Ashok Kumar,et al.  Herpes simplex virus 1 infection induces the expression of proinflammatory cytokines, interferons and TLR7 in human corneal epithelial cells , 2006, Immunology.

[92]  J. Blaho,et al.  Herpes simplex virus 2 modulates apoptosis and stimulates NF-κB nuclear translocation during infection in human epithelial HEp-2 cells , 2005 .

[93]  Keita Hara,et al.  Bactericidal Actions of a Silver Ion Solution on Escherichia coli, Studied by Energy-Filtering Transmission Electron Microscopy and Proteomic Analysis , 2005, Applied and Environmental Microbiology.

[94]  L. Chiang,et al.  Acetone, ethanol and methanol extracts of Phyllanthus urinaria inhibit HSV-2 infection in vitro. , 2005, Antiviral research.

[95]  M. Yacamán,et al.  Interaction of silver nanoparticles with HIV-1 , 2005, Journal of nanobiotechnology.

[96]  C. Kao,et al.  Study of the viral infections and cytokines associated with recurrent aphthous ulceration. , 2005, Microbes and infection.

[97]  R. Wolf,et al.  The life-threatening complications of dermatologic therapies. , 2005, Clinics in dermatology.

[98]  G. Kleymann.  Agents and strategies in development for improved management of herpes simplex virus infection and disease , 2005, Expert opinion on investigational drugs.

[99]  T. Mettenleiter.  Budding events in herpesvirus morphogenesis. , 2004, Virus research.

[100]  D. Bernstein,et al.  Treatment of herpes simplex virus infections. , 2004, Antiviral research.

[101]  David Sutton,et al.  Herpes Simplex Virus Resistance to Acyclovir and Penciclovir after Two Decades of Antiviral Therapy , 2003, Clinical Microbiology Reviews.

[102]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[103]  B. Matthews,et al.  Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication. , 2002, Antiviral research.

[104]  F. Cui,et al.  A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. , 2000, Journal of biomedical materials research.

[105]  G. Loy,et al.  Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. , 2000, Antiviral research.

[106]  J. Spaltro,et al.  Virus assay methods: accuracy and validation. , 1998, Biologicals : journal of the International Association of Biological Standardization.

[107]  D M Coen,et al.  Molecular mechanisms of antiviral resistance. , 1995, Antiviral research.

[108]  H. Balfour,et al.  Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. , 1994, Journal of acquired immune deficiency syndromes.

[109]  R. Whitley.  Herpes Simplex Virus Infections of the Central Nervous System , 1991, Drugs.

[110]  R. Watson,et al.  A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis , 1980, Nature.

[111]  H. Schaeffer,et al.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[112]  B. Roizman,et al.  Regulation of Herpesvirus Macromolecular Synthesis I. Cascade Regulation of the Synthesis of Three Groups of Viral Proteins , 1974, Journal of virology.

[113]  W. Hou,et al.  Antiviral activity of arbidol hydrochloride against herpes simplex virus I in vitro and in vivo. , 2018, International journal of antimicrobial agents.

[114]  Chun-ching Lin,et al.  Yin Chen Hao Tang, a Chinese prescription, inhibits both herpes simplex virus type-1 and type-2 infections in vitro. , 2008, Antiviral research.

[115]  S. Grelli,et al.  Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A. , 2007, Annals of the New York Academy of Sciences.

[116]  B. Marinari,et al.  Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes. , 2006, The Journal of biological chemistry.

[117]  J. Blaho,et al.  Herpes simplex virus 2 modulates apoptosis and stimulates NF-kappaB nuclear translocation during infection in human epithelial HEp-2 cells. , 2005, Virology.

[118]  S. Bachenheimer,et al.  Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway. , 2004, Journal of virology.

[119]  P. Wutzler.  Antiviral therapy of herpes simplex and varicella-zoster virus infections. , 1997, Intervirology.

[120]  R. Kozłowski,et al.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.

[121]  P. Paz,et al.  Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. , 1992, Virology.

[122]  D. Gamus,et al.  Herpetic imprint on privileged areas of its target organs: local latency and reactivation in herpetic keratitis. , 1988, Metabolic, pediatric, and systemic ophthalmology.